Table 2.
Name | Panel size | Study type | Study size | Clinical use | Cancer type | References |
---|---|---|---|---|---|---|
7-miR panel | 7 | Multicenter, retrospective, longitudinal study | 257 patients for discovery, 352 and 139 patient from two cohorts for validation | Early detection | Hepatocellular carcinoma | (106) |
6-miR panel | 6 | MicroRNA expression analysis | 40 patients for discovery, 138 for validation | Risk of disease progression | Stage II colon cancer | (107) |
MiROvaR | 35 | Cohort study | 179 patients for discovery, 263 and 452 patients from two cohorts for validation | Early relapse or progression | Epithelial ovarian cancer | (108) |
6-miR panel | 6 | Phase II clinical trial | 2 cell lines for discovery, 97 patients for validation | Early relapse or progression | Prostate cancer | (110) |